Clinical Supply

We deliver clinical supply through manufacturing and packaging workflows aligned with GMP and multi‑market requirements.

Drug Manufacturing banner

Clinical supply 
for GMP compliance

We deliver clinical supply with controlled label versioning and reconciliation.

Clinical supply operates within strict GMP requirements, requiring a CDMO that manages manufacturing and packaging as controlled operations, ensuring complete batch documentation and full product accountability.

At Groupe PARIMA, we align packaging requirements, material flows, and unit reconciliation to support reliable clinical supply and a clear path toward commercial presentation.

We deliver clinical supply with controlled GMP packaging and documentation aligned to investigational use.

Clinical Supply Priorities

Clinical programs depend on controlled change, short-run execution, and GMP packaging discipline that keeps documentation aligned.

Card 01

Flexible batch Sizes

We offer flexible batch sizes to align with clinical needs, supporting efficient scale adjustments throughout development.

Card 02

Execution That Scales

We plan clinical batches with a defined scale-up path and packaging configuration that supports commercialization.

Card 03

TRACEABLE DOCUMENTATION

We maintain GMP-aligned documentation and material flows to keep manufacturing and packaging execution traceable.

Capabilities That Support Clinical Readiness

Clinical supply requires controlled manufacturing and packaging workflows that stay aligned with protocol updates and multi‑market label builds. We perform clinical execution to support the global clinical study requirements.

01
Card 01

Clinical Batch Manufacturing

We manufacture non‑sterile liquids, suspensions, and semi‑solid drug products for clinical programs under GMP execution.

02
Card 02

Clinical Packaging Execution

We execute clinical packaging, component readiness, and configuration control aligned with batch documentation and release needs.

03
Card 03

Clinical Study 
Support

We provide technical expertise and create the required documentation with stability data to effectively support clinical studies across all stages.

Resources

Practical resources that clarify clinical supply controls and guide execution decisions, from initial clinical batches through scale-up.

Groupe PARIMA
2026/04/27
How Drug Product Formulation Works: Topical, Oral, and Nasal Liquid and Semi-Solid Dosage Forms
Groupe PARIMA
2026/03/18
How Early API Characterization Can Reduce Formulation and Scale-up Risks
Groupe PARIMA
2025/10/23
Topical 101: A Guide to Complex Dermatology Formulation Development
Groupe PARIMA
2026/04/27
How Drug Product Formulation Works: Topical, Oral, and Nasal Liquid and Semi-Solid Dosage Forms
Groupe PARIMA
2026/03/18
How Early API Characterization Can Reduce Formulation and Scale-up Risks
Groupe PARIMA
2025/10/23
Topical 101: A Guide to Complex Dermatology Formulation Development

Contact us

Discuss Your Clinical Supply Plan

Let’s review your clinical batch and timeline to align execution with market requirements.